by Michele Taylor | Feb 23, 2016
According to an article by Zachary Brennan, RAPS, the Government Accountability Office (GAO) issued a report in December 2015 that in review of the Document Archiving, Reporting and Regulatory Tracking System (DARRTS), the FDA has not formally tracked 144 issues...
by Michele Taylor | Feb 17, 2016
Sharing an excellent panel discussion on clinical research featuring Pearl Pathways’ CEO and President, Diana Caldwell here. Put the IHIF monthly seminar series on your calendar for Life Science updates from experts in the field – click here for information. Pearl...
by Michele Taylor | Feb 16, 2016
Our recent blog post, Medical Device “Emerging Signals”, updated about FDA’s intent to notify the public about “new information about a medical device used in clinical practice”. FDA’s intent to alert the public to the most current information known about a medical...
by Michele Taylor | Feb 11, 2016
On February 16th, the Indiana Health Industry Forum (IHIF) and Barnes & Thornburg present “Clinical Trials from a Study Site Perspective”. Pearl Pathways’ own President and CEO, Diana Caldwell will be a panelist. This luncheon event takes place at the Barnes...
by Michele Taylor | Feb 5, 2016
Brandwood Biomedical is hosting a webinar, What’s new with China FDA in 2016. Get the latest information on Decree 650 and changes in device guidance, regulations, and in-China clinical trials from Brandwood Biomedical Director of China Operations, Steven Wen. Free...